SKK
ALDR

Shepherd Kaplan Krochuk’s Alder Biopharmaceuticals ALDR Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11,900
Closed -$151K – 269
2018
Q1 		$151K Buy
+11,900
New +$172K 0.09% 201

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Shepherd Kaplan Krochuk's ALDR Position: Q2 2018 in Review

Shepherd Kaplan Krochuk sold out of Alder Biopharmaceuticals (ALDR) in Q2 2018, closing a stake of 11,900 shares — an estimated $151K sold.

Shepherd Kaplan Krochuk first reported a position in ALDR in Q1 2018 and held it in 1 quarter. The position peaked at $151K in Q1 2018. 139 funds tracked by Wall St. Rank hold ALDR as of Q2 2018.

  • Shepherd Kaplan Krochuk reported no remaining Alder Biopharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 11,900 Alder Biopharmaceuticals shares in Q2 2018, an estimated $151K.
  • Shepherd Kaplan Krochuk first reported a position in Alder Biopharmaceuticals in Q1 2018 and held it in 1 quarter.
  • Shepherd Kaplan Krochuk's Alder Biopharmaceuticals position peaked at $151K in Q1 2018.
  • 139 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2018.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2018, filed 14 Aug 2018.